Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Vancouver, British Columbia, Canada
SEC filing record 1 source field available
Fiscal year end
30 June
InMed Pharmaceuticals Inc. has filed 492 SEC EDGAR filings since 17 Jan 2018

SEC filing history

Showing 251-275 of 492 matching filings.

Per page
25
Current page
11
4

4 filing

Filing date
15 Nov 2022
Reporting date
14 Nov 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
15 Nov 2022
Reporting date
14 Nov 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
15 Nov 2022
Reporting date
14 Nov 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
15 Nov 2022
Reporting date
14 Nov 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-39685

CURRENT REPORT

Filing date
15 Nov 2022
Reporting date
11 Nov 2022
Next action
Verify source filing
S-8 File 333-268356

REGISTRATION STATEMENT

Filing date
14 Nov 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
10-Q File 001-39685

QUARTERLY REPORT

Filing date
14 Nov 2022
Reporting date
30 Sep 2022
Next action
Verify source filing
DEF 14A File 001-39685

DEFINITIVE PROXY STATEMENT

Filing date
28 Oct 2022
Reporting date
15 Dec 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
DEFA14A File 001-39685

DEFINITIVE ADDITIONAL MATERIALS

Filing date
28 Oct 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-39685

CURRENT REPORT

Filing date
26 Oct 2022
Reporting date
26 Oct 2022
Next action
Verify source filing
424B3 File 333-267831

PROSPECTUS

Filing date
19 Oct 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
EFFECT File 333-267831

EFFECT filing

Filing date
18 Oct 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
CORRESP

CORRESP filing

Filing date
14 Oct 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
UPLOAD

UPLOAD filing

Filing date
14 Oct 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
S-1 File 333-267831

REGISTRATION STATEMENT

Filing date
12 Oct 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
EFFECT File 333-265731

EFFECT filing

Filing date
07 Oct 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
EFFECT File 333-264187

EFFECT filing

Filing date
07 Oct 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
EFFECT File 333-262533

EFFECT filing

Filing date
07 Oct 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
EFFECT File 333-257858

EFFECT filing

Filing date
07 Oct 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
EFFECT File 333-253925

EFFECT filing

Filing date
07 Oct 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-39685

CURRENT REPORT

Filing date
29 Sep 2022
Reporting date
29 Sep 2022
Next action
Verify source filing
10-K/A File 001-39685

AMENDMENT NO. 1 TO FORM 10-K

Filing date
28 Sep 2022
Reporting date
30 Jun 2022
Next action
Verify source filing
8-K File 001-39685

CURRENT REPORT

Filing date
23 Sep 2022
Reporting date
23 Sep 2022
Next action
Verify source filing
10-K File 001-39685

ANNUAL REPORT

Filing date
23 Sep 2022
Reporting date
30 Jun 2022
Next action
Verify source filing
8-K File 001-39685

CURRENT REPORT

Filing date
20 Sep 2022
Reporting date
19 Sep 2022
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .